This filing contains no financial data or operational updates. Monitor future filings for any business developments or financial results. The addition of advisory board members with capital markets experience (Yarbrough, Mathias) could signal future capital-raising or strategic initiatives, but no such plans are disclosed here.
Price Chart
Executive Summary
BioForce NanoSciences Holdings filed an 8-K disclosing the establishment of an Advisory Board and the appointment of Scott Mager as General Counsel and Director, and Richard Kaiser as Interim CEO. The filing is purely administrative, detailing the biographies of new advisory board members Stuart Yarbrough and Edward Mathias, and providing an update on the board and officer structure. No financial data, business updates, or material events were disclosed, making this a routine governance filing with no immediate trading implications.
Key Facts
- Established an Advisory Board on May 19, 2026, with a three-year term ending May 19, 2029.
- Appointed Stuart Yarbrough and Edward Mathias to the Advisory Board.
- Appointed Scott Mager as General Counsel on May 19, 2026, and as a Director on June 15, 2026.
- Appointed Richard Kaiser as Interim CEO on June 17, 2026, who also serves as CFO, Secretary, and Director.
- No financial figures, business operations updates, or material agreements were disclosed in the filing.
Financial Impact
No financial impact disclosed. Filing is administrative in nature.
Risk Factors
- No material risks disclosed in this filing. The company's risk profile remains unchanged.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (BFNH) — Batch item 1 | 0001091818-26-000124 |
| Document: 0001091818-26-000124-index-headers.html | 0001091818-26-000124 |
| Document: 0001091818-26-000124-index.html | 0001091818-26-000124 |
| Document: 0001091818-26-000124.txt | 0001091818-26-000124 |
| 8-K Filing (BFNH) — Batch item 5 | 0001091818-26-000124 |
| Document: 0001091818-26-000124-index-headers.html | 0001091818-26-000124 |
| Document: 0001091818-26-000124-index.html | 0001091818-26-000124 |
| Document: 0001091818-26-000124.txt | 0001091818-26-000124 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 8-K | $8.89 | awaiting T+20 | awaiting T+20 | $7.40 (−16.76%) |
Sep 4, 2026 7w ago | 8-K | $6.10 $7.01 | ▼ −14.92% | ▼ −14.07% | $7.40 (−21.31%) |
Aug 18, 2026 10w ago | 8-K | $3.84 $10.01 | ▲ +160.68% | ▲ +161.67% | $7.40 (+92.71%) |
Aug 14, 2026 10w ago | 8-K | $3.40 $9.71 | ▲ +185.59% | ▲ +187.58% | $7.40 (+117.65%) |
Jul 7, 2026 16w ago | 8-K | $2.02 $1.85 | ▼ −8.42% | ▼ −11.57% | $7.40 (+266.34%) |
Jul 1, 2026 16w ago | 8-K | $1.69 $1.90 | ▲ +12.43% | ▲ +12.97% | $7.40 (+337.87%) |
Jun 18, 2026 18w ago | 8-K | $1.79 $1.50 | ▼ −16.20% | ▼ −15.58% | $7.40 (+313.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers